Portfolio Companies News
October 22, 2018Strongbridge Biopharma plc Presents...
As Previously Reported, SONICS Met its Primary Endpoint With 30 Percent of the ITT Patient Population Reaching & Maintaining Mean Urinary Free Cortisol (mUFC) Normalization Following Six Months of Maintenance Therapy Without a Dose Increase ~ ~ RECORLEV Monotherapy Normalized UFC Initially in... read more
October 22, 2018Göran Wessman resigns from the Boa...
Mölndal, October 22, 2018 - Due to personal reasons, Göran Wessman has chosen to resign from the Board of Directors of Vicore Pharma Holding AB (publ) and will instead join the nomination committee of Vicore Pharma Holding AB (publ) as representative of Protem Wessman AB. Göran Wessman, board ... read more
October 22, 2018BONESUPPORT starts selling CERAMENT...
25 independent distributors contracted Total of 512 distributor reps now selling CERAMENT BVF New distribution network will positively impact North American reported sales and net margins Lund, Sweden, 08:00 CET, 22 October 2018 - BONESUPPORT, an emerging leader in orthobiologics for... read more
October 18, 2018GenSight Biologics reports positive...
• Clinically meaningful improvement of +15 ETDRS letters in visual acuity of treated eyes at Week 72 • Continuous bilateral improvement of both visual acuity and contrast sensitivity • Significantly higher proportion of drug-treated eyes achieved clinically meaningful improvement in contrast... read more
October 17, 2018Nordic Nanovector ASA: Change of Da...
Oslo, Norway, 17 October 2018 Nordic Nanovector ASA (OSE: NANO) announces it will present its results for the third quarter 2018 on Tuesday, 6 November 2018 (previously scheduled for Tuesday, 21 November), and will host a results presentation and webcast on the same day (details will be... read more
July 24, 2018Q2 2018 General Market Overview
Since the start in 1996, HealthCap funds have invested in 112 portfolio companies.
41 of the portfolio companies have been taken public on nine different markets.
25 of the portfolio companies’ pharmaceutical products have been approved for marketing.
Since the start in 1996, HealthCap has helped build 7 companies with a valuation of USD 1 billion or more and 35 companies with a valuation of SEK 1 billion or more.